Jaden Schaefer

And essentially, it's going to go and grab all of the latest evidence-based medical research.

And it's also going to grab the patient's history and all of their responses and pull that all together in a way that is just so much more personalized.

And essentially, it's really similar to what systems like open evidence are kind of like combining the retrieval of these like up-to-date studies with the structured clinical logic and put it all together.

This is what their CEO, Dolly Wall, said.

He said, AI is giving the advice, but the real doctors are actually signing off on it.

So I think right now the company is like pretty upfront about what they don't handle.

They said they don't do anything urgent or, you know, emergent conditions that are all of that is kind of redirected to emergency rooms or an urgent care center.

Any cases that require physical exams are also put to, you know, in-person providers.

And then Lotus kind of, they just position themselves as a replacement for the routine primary care access.

And so they're not saying like, look, we're like a substitute for hands-on medicine or something like that.

Obviously, super, super ambitious.

There is a lot of regulatory risk that comes with that.

Healthcare in the US is obviously kind of governed by a patchwork of state-level licensing rules.

And I know for my own family, I have an uncle that's a doctor,

moving when he when his family moves, he's moved between many different states before and originally is from Canada and getting the licenses in every state and board certification approval.

Like there's a lot that goes into just a doctor moving between states, sometimes months or years for some of this stuff.

And so this is it's a complicated kind of process.

I think doctors are typically kind of restricted to treating patients only where they're licensed.

And if they want to move somewhere, then they have that whole issue, which I think is just another strain on the healthcare system that a system like this could help with and help alleviate.

So automating a big chunk of all of this kind of clinical decision making has a bunch of, I think, additional scrutiny around liability.